1-10 of 10
Adriano Venditti, M.D.
Close
Sort by
Journal Articles

Clinical Monoclonal B Cell Lymphocytosis Is a Strong Favorable Prognosticator Independent From Biological and Clinical Parameters,

Giovanni Del Poeta, M.D., Maria Ilaria Del Principe, M.D., Francesco Buccisano, M.D., Annalisa Biagi, M.D., Pietro Bulian, Fabrizio Luciano, Ph.D., Antonella Zucchetto, Ph.D., Luca Maurillo, M.D., Pasquale Niscola, M.D., Alessio Pio Perrotti, M.D., Adriano Venditti, M.D., Valter Gattei, Paolo de Fabritiis, Sergio Amadori, MD
Journal: Blood
Blood (2011) 118 (21): 3887.
https://doi.org/10.1182/blood.V118.21.3887.3887
Published: 2011
Journal Articles

Immunotherapeutic Maintenance Strategy Prolongs Response Duration and Overall Survival Preventing Relapse in Chronic Lymphocytic Leukemia (CLL),

Giovanni Del Poeta, M.D., Maria Ilaria Del Principe, M.D., Pietro Bulian, Francesco Buccisano, M.D., Annalisa Biagi, M.D., Benedetta Neri, MD, Alessio Pio Perrotti, M.D., Antonella Zucchetto, Ph.D., Luca Maurillo, M.D., Pasquale Niscola, M.D., Adriano Venditti, M.D., Paolo de Fabritiis, Valter Gattei, Sergio Amadori, MD
Journal: Blood
Blood (2011) 118 (21): 3906.
https://doi.org/10.1182/blood.V118.21.3906.3906
Published: 2011
Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of Low Dose IL-2 Maintenance,

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, MD, Stijn J.M. Halkes, Jean-Pierre Marie, Boris Labar, Adriano Venditti, M.D., Petra Muus, MD, PhD, Martin Mistrik, MD, PhD, Andrea Camera, Domenico Magro, MD, Lorella Melillo, Dominique Bron, Silvana Magrin, Dominik Selleslag, Domenico Pastore, Silvia Trisolini, Paola Fazi, Matthias Karrasch, Marco Vignetti, Sergio Amadori, MD, Theo M. de Witte, MD, Giovanna Meloni, MD
Journal: Blood
Blood (2011) 118 (21): 3612.
https://doi.org/10.1182/blood.V118.21.3612.3612
Published: 2011
Journal Articles

The Incidence of Central Nervous System Involvement in AML: A SAL-Tor Vergata Analysis

Nael Alakel, MD, Maria Ilaria Del Principe, Friedrich Stölzel, MD, Brigitte Mohr, Uta Oelschlaegel, PhD, Sergio Amadori, MD, Gerhard Ehninger, MD, Adriano Venditti, M.D., Markus Schaich, MD
Journal: Blood
Blood (2011) 118 (21): 4236.
https://doi.org/10.1182/blood.V118.21.4236.4236
Published: 2011
Journal Articles

Nucleophosmin Gene Mutations Exhibit High Spontaneous Apoptosis and Favorable Prognosis in Acute Myeloid Leukemia.

Giovanni Del Poeta, MD, Emanuele Ammatuna, M.D., Serena Zaza, Ph.D., Francesco Buccisano, M.D., Tiziana Ottone, Ph.D., Maria Ilaria Del Principe, M.D., Serena Lavorgna, Ph.D., Gianfranco Catalano, M.D., Luca Maurillo, M.D., Fabrizio Luciano, Ph.D., Paolo de Fabritiis, M.D., Adriano Venditti, M.D., Sergio Amadori, M.D., Francesco Lo Coco, M.D.
Journal: Blood
Blood (2007) 110 (11): 3480.
https://doi.org/10.1182/blood.V110.11.3480.3480
Published: 2007
Journal Articles

Rituximab Consolidation and Maintenance Immunotherapy Improve Outcome in B-Cell Chronic Lymphocytic Leukemia.

Giovanni Del Poeta, MD, Maria Ilaria Del Principe, M.D., Luca Maurillo, M.D., Francesco Buccisano, M.D., Gianfranco Catalano, M.D., Adriano Venditti, M.D., Antonella Zucchetto, Ph.D., Alessio Pio Perrotti, M.D., Valter Gattei, M.D., Paolo de Fabritiis, M.D., Sergio Amadori, M.D.
Journal: Blood
Blood (2007) 110 (11): 2035.
https://doi.org/10.1182/blood.V110.11.2035.2035
Published: 2007
Journal Articles

High CD69 Protein Expression Predicts a Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Giovanni Del Poeta, MD, Maria Ilaria Del Principe, M.D., Fabrizio Luciano, Ph.D., Luca Maurillo, M.D., Francesco Buccisano, M.D., Gianfranco Catalano, M.D., Laura Giannì, M.D., Angela Coletta, Ph.D., Antonella Zucchetto, Ph.D., Pasquale Niscola, M.D., Adriano Venditti, M.D., Paolo de Fabritiis, M.D., Valter Gattei, M.D., Sergio Amadori, M.D.
Journal: Blood
Blood (2007) 110 (11): 750.
https://doi.org/10.1182/blood.V110.11.750.750
Published: 2007
Journal Articles

Addition of Rituximab to Fludarabine Improves Progression Free Survival in Untreated ZAP-70 Negative Chronic Lymphocytic Leukemia (CLL).

Maria Ilaria Del Principe, M.D., Giovanni Del Poeta, M.D., Luca Maurillo, M.D., Adriano Venditti, M.D., Francesco Buccisano, M.D., Elisabetta Abruzzese, M.D., Maria Irno Consalvo, Ph.D., Daniela Piccioni, M.D., Valter Gattei, M.D., Francesco Lo Coco, M.D., Sergio Amadori, M.D.
Journal: Blood
Blood (2004) 104 (11): 477.
https://doi.org/10.1182/blood.V104.11.477.477
Published: 2004
Journal Articles

ZAP-70 Protein Retains Its Prognostic Significance within Interphase Cytogenetic Groups in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Maria Ilaria Del Principe, M.D., Giovanni Del Poeta, M.D., Maria Christina Cox, M.D., Paola Panetta, Ph.D., Luca Maurillo, M.D., Adriano Venditti, M.D., Maria Irno Consalvo, Ph.D, Valter Gattei, M.D., Francesco Lo Coco, M.D., Sergio Amadori, M.D.
Journal: Blood
Blood (2004) 104 (11): 2806.
https://doi.org/10.1182/blood.V104.11.2806.2806
Published: 2004
Journal Articles

Clinical Significance of Apoptosis Is Independent from Proliferation in Acute Myeloid Leukemia (AML).

Giovanni Del Poeta, M.D., Maria Ilaria Del Principe, M.D., Adriano Venditti, M.D., Luca Maurillo, M.D., Francesco Buccisano, M.D., Maria Irno Consalvo, Ph.D., Carla Mazzone, M.D., Maria Christina Cox, M.D., Antonio Bruno, M.D., Francesco Lo Coco, M.D., Sergio Amadori, M.D.
Journal: Blood
Blood (2004) 104 (11): 198.
https://doi.org/10.1182/blood.V104.11.198.198
Published: 2004